Ranbaxy gets Australia nod for anti-fungal drug

Ranbaxy gets Australia nod for anti-fungal drug
Comment E-mail Print Share
First Published: Fri, Mar 06 2009. 10 46 PM IST
Updated: Fri, Mar 06 2009. 10 46 PM IST
Mumbai/Delhi: Ranbaxy Laboratories Ltd said on Friday its unit had received approval from the Australian health regulator to market anti-fungal drug Terbinafine, a generic version of Novartis AG’s Lamisil tablets.
Ranbaxy Australia, the wholly-owned subsidiary of the company, has received an approval from the Therapeutic Goods Administration for the registration of Sebifin Terbinafine tablets in Australia, the drug manufacturer said in a statement. With the approval of this tablet, Ranbaxy now has a total number of 26 molecules approved for marketing in Australia.
Comment E-mail Print Share
First Published: Fri, Mar 06 2009. 10 46 PM IST